A proof of the specificity of methiothepin to inhibit Ptch1 drug efflux activity only in cancer cells was brought by the quantification of doxorubicin in the tumors and the hearts of mice xenografted with adrenocortical carcinoma cells [11]. The gene discussed is PTCH1; the disease is cancer.